Early clinical investigation of Viozan (sibenadet HCl), a novel D2 dopamine receptor, beta2-adrenoceptor agonist for the treatment of chronic obstructive pulmonary disease symptoms.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples